Therefore, this study, based on a retrospective analysis of clinical data, aims to investigate the relationship between fasting glucagon levels and the risk of CAD in T2DM patients, providing new insights for the early warning and precise intervention of diabetic cardiovascular complications. The gene discussed is GCG; the disease is coronary artery disorder.